心臟監測的全球市場 - 成長,趨勢,預測(2019年∼2024年)

Global Cardiac Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 390864
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
心臟監測的全球市場 - 成長,趨勢,預測(2019年∼2024年) Global Cardiac Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 112 Pages




第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 心血管疾病的罹患率的增加
    • 技術進步
    • 家庭基礎,照護現場(PoC),及遠隔監視監控系統的需求
  • 市場阻礙因素
    • 置入式監測設備造成感染疾病的危險性
    • 不利的償付制度
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各設備類型
    • 心電圖監視器
    • 活動錄音機
    • 植入式心臟迴路錄音機
    • 心律調節器
    • 心臟去顫器
    • 心臟再同步化治療(CRT)設備
    • 智慧穿戴式設備
    • 其他
  • 各用戶
    • 醫院、診療所
    • 居家照護
    • 門診外科中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Medtronic
    • Abbott Laboratories
    • Boston Scientific Corporation
    • GE Healthcare
    • iRhythm Technologies Inc
    • Biotronik
    • Livanova
    • Hill-Rom Holdings
    • Schiller
    • Biotelemetry
    • Applied Cardiac System

第7章 市場機會及未來趨勢


Product Code: 55315

Market Overview

Global cardiac monitoring market is driven by an increase in the prevalence of heart diseases, growing aging population who are very susceptible to the coronary heart diseases and technological developments in cardiac monitoring devices that minimizing the chances of infection and improved efficiency of devices. According to the WHO reports, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that cardiovascular diseases take the life of 17.9 million people every year, 31% of all global deaths. Furthermore, cardiac monitoring is one of the most reliable and efficient options for the monitoring of various cardiac conditions. However, rising incidences of infection, high cost associated with the monitoring and stringent regulatory procedures may act as restraints for the growth of global cardiac monitoring market over the forecast period.

Scope of the Report

Continuous cardiac monitoring is an important tool in the clinical assessment of patients with a variety of conditions. It allows the detection of changes in heart rate and rhythm and is essential in the detection of life-threatening arrhythmias. This is achieved using a cardiac monitor, connected to a cable lead and skin electrodes, which captures the electrical activity predominantly through a single view. There are various types of cardiac monitors available in the market.

Key Market Trends

ECG Monitor to dominate the Global Cardiac Monitoring Market

As there is an increase in the incidence of cardiovascular diseases (CVD), therein long-term ECG monitoring is necessary. Usually, this procedure is possible in hospitals. However, with the introduction of wireless ECG, the doctors can monitor and diagnose the patient remotely and on time. There are two different types of ECG monitors available in the market such as Monitoring ECG Systems and Diagnostic ECG Systems. Development of commercially advanced devices, with enabled Bluetooth sensor technology and mobile app technology, are anticipated to drive the popularity of ECG monitors segment globally. Furthermore, technological advancements and product innovations taking place in the development of ECG devices which are likely to propel market growth. For example, in 2018, Qardio, Inc., has received the approval from Australia's Therapeutic Goods Administration (TGA) for QardioCore, its revolutionary ECG monitor.

North America held the largest market share in the Global Cardiac Monitoring Market

North American holds the leading position in the Cardiac Monitoring market. Especially US and Canada owing to a drastic increase in the patient pool of cardiovascular diseases. As per the report from the American Heart Association on heart disease and stroke, in 2017, over approximately 800,000 deaths occurred due to cardiovascular disease. Furthermore, continuous advancements in the technology, growing awareness in patients about cardiac monitoring, well-established healthcare infrastructure, and favorable reimbursement policies are expected to boost the cardiac monitoring market in the North America region. For instance, In April 2019, Stryker has launched the company's newest defibrillation solution, the LIFEPAK® CR2 defibrillator with LIFELINKcentral™ AED program manager, in the United States.

Competitive Landscape

Cardiac monitoring market is exceptionally fragmented and focused because of the presence of many large, medium, and small players. The multinational players possess a substantial share of the worldwide market. The companies in the cardiac monitoring market are focusing on various growth strategies such to enhance their market presence such as M&A, partnerships, collaborations, geographical expansions, new product launches. For instance, In October 2017, Abbott has received U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx™ Insertable Cardiac Monitor (ICM).

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidences of Cardiovascular Diseases
    • 4.2.2 Advancements in the Technology
    • 4.2.3 Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems
  • 4.3 Market Restraints
    • 4.3.1 Risk of Infection Due to Implantable Monitoring Devices
    • 4.3.2 Unfavourable reimbursement policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 Device Type
    • 5.1.1 ECG Monitor
    • 5.1.2 Event Recorder
    • 5.1.3 Implantable Cardiac Loop Recorder
    • 5.1.4 Pacemaker
    • 5.1.5 Defibrillator
    • 5.1.6 Cardiac Resynchronization Therapy (CRT) Devices
    • 5.1.7 Smart Wearable
    • 5.1.8 Others
  • 5.2 End Users
    • 5.2.1 Hospitals & Clinics
    • 5.2.2 Home Care Settings
    • 5.2.3 Ambulatory Surgical Centers
  • 5.3 Geography
    • 5.3.1 North America
      • US
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Medtronic
    • 6.1.2 Abbott Laboratories
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 GE Healthcare
    • 6.1.5 iRhythm Technologies Inc
    • 6.1.6 Biotronik
    • 6.1.7 Livanova
    • 6.1.8 Hill-Rom Holdings
    • 6.1.9 Schiller
    • 6.1.10 Biotelemetry
    • 6.1.11 Applied Cardiac System